IP Library Granted Patent US 11,168,309
Granted Patent B2
US 11,168,309 · App. 16/912,374 · Granted Nov 9, 2021

Uridine diphosphate-dependent glycosyltransferase enzyme

Inventors: Jason Eric Donald (Watertown, MA); Ajikumar Parayil Kumaran (Lexington, MA); Aaron Love (Boston, MA); Christopher Toomey (Cambridge, MA); Christine Nicole S. Santos (Newton, MA)
Assignee: MANUS BIO INC.
C12N9/1051C12N15/52C12P19/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,168,309
App. No.
16/912,374
Granted
Nov 9, 2021
Kind
B2
Abstract

In various aspects, the present invention provides uridine diphosphate-dependent glycosyltransferase (UGT) enzymes capable of catalyzing the transfer of a monosaccharide moiety from a NDP-sugar to the 3′ carbon of a sugar moiety of a substrate, such as a terpenoid glycan, thereby functioning as a “1-3 UGT.” In other aspects, the invention provides polynucleotides encoding the 1-3 UGT, and host cells comprising the same. In still other aspects, the invention provides methods for preparing glycosylated substrates, including steviol glycosides, using the enzyme and host cells of this disclosure.

Claims (34)

1. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6, wherein:

the enzyme has an insertion with respect to SEQ ID NO: 1 of a flexible and hydrophilic sequence of 6 to 12 amino acids that is predominately Glycine and Serine residues after the position corresponding to position 155 of SEQ ID NO: 5; and

the enzyme retains one or more of:

a glycine (G) at the position corresponding to position 54 of SEQ ID NO: 5;

a leucine (L) at the position corresponding to position 111 of SEQ ID NO: 5; and

a methionine (M) at the position corresponding to position 183 of SEQ ID NO: 5.

2. The enzyme of claim 1 , wherein the amino acid sequence is at least 95% identical to SEQ ID NO: 5 or SEQ ID NO: 6.

3. The enzyme of claim 1 , wherein the enzyme has Gly at the position corresponding to position 54 of SEQ ID NO: 5, Leu at the position corresponding to position 111 of the SEQ ID NO: 5, and a Met at the position corresponding to position 183 of SEQ ID NO: 5.

4. The enzyme of claim 1 , wherein the insertion is GSGGSG (SEQ ID NO: 7) or GSGGSGGSG (SEQ ID NO: 8).

5. The enzyme of claim 1 , wherein the enzyme comprises a deletion of at least three amino acids corresponding to amino acids E225 to T232 with respect to the amino acid sequence of SEQ ID NO: 6.

6. The enzyme of claim 5 , wherein the enzyme comprises a deletion of the amino acids corresponding to amino acids E225 to T232 of SEQ ID NO: 6.

7. The enzyme of claim 1 , wherein the enzyme comprises an amino acid substitution at one or more positions corresponding to position 72, position 305, position 345, and position 428 of SEQ ID NO: 6.

8. The enzyme of claim 7 , wherein the enzyme comprises one or more amino acid substitutions selected from: a glutamine (Q) at the position corresponding to position 72 of SEQ ID NO: 6; a cysteine (C) at the position corresponding to position 305 of SEQ ID NO: 6; a phenylalanine (F) at the position corresponding to position 345 of SEQ ID NO: 6; and an isoleucine (I) at the position corresponding to position 428 of SEQ ID NO: 6.

9. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6, wherein the UGT enzyme comprises:

a glycine (G) at the position corresponding to position 54 of SEQ ID NO: 5;

a leucine (L) at the position corresponding to position 111 of SEQ ID NO: 5; and

a methionine (M) at the position corresponding to position 183 of SEQ ID NO: 5.

10. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that has at least 85% sequence identity to the amino acid sequence of SEQ ID NO:1, and comprising a deletion of amino acids corresponding to E74 to T81 of SEQ ID NO: 1.

11. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme that is a circular permutant of SrUGT76G1 (SEQ ID NO: 1), and having from 1 to 20 amino acid modifications independently selected from amino acid substitutions, deletions, and insertions with respect to the corresponding position of SEQ ID NO:1, with the proviso that the circular permutant has a deletion of amino acids corresponding to amino acids E74 to T81 of SEQ ID NO: 1.

12. The enzyme of claim 5 , wherein the enzyme comprises a deletion of at least five amino acids corresponding to amino acids E74 to T81 with respect to the amino acid sequence of SEQ ID NO: 6.

13. The enzyme of claim 7 , wherein the enzyme comprises a substitution of glutamine (Q) or asparagine (N) at the position corresponding to position 72 of SEQ ID NO: 6.

14. The enzyme of claim 7 , wherein the enzyme comprises a neutral hydrophilic amino acid selected from cysteine (C), Serine (S), or Threonine (T) at the position corresponding to position 305 of SEQ ID NO: 6.

15. The enzyme of claim 7 , wherein the enzyme comprises a substitution of phenylalanine (F) or Tryptophan (W) at the position corresponding to position 345 of SEQ ID NO: 6.

16. The enzyme of claim 7 , wherein the enzyme comprises a substitution of isoleucine (I), valine (V), or alanine (A) at the position corresponding to position 428 of SEQ ID NO: 6.

17. The enzyme of claim 7 , wherein the enzyme comprises 2, 3, or 4 of the following substitutions with respect to SEQ ID NO: 6: S72Q, A305C, Y345F, and L428I.

18. A uridine diphosphate-dependent glycosyltransferase (UGT) enzyme comprising an amino acid sequence that is at least 85% identical to the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 6, and comprising a deletion of at least three amino acids corresponding to amino acids E225 to T232 with respect to SEQ ID NO: 6.

19. The UGT enzyme of claim 18 , wherein the enzyme comprises a deletion of at least five amino acids corresponding to amino acids E225 to T232 with respect to SEQ ID NO: 6.

20. The UGT enzyme of claim 18 , wherein the enzyme comprises a deletion of the amino acids corresponding to amino acids E225 to T232 with respect to SEQ ID NO: 6.

21. The UGT enzyme of claim 18 , wherein the enzyme is at least 90% identical to SEQ ID NO: 5 or SEQ ID NO: 6.

22. The UGT enzyme of claim 18 , wherein the enzyme is at least 95% identical to SEQ ID NO: 5 or SEQ ID NO: 6.

23. A polynucleotide encoding the enzyme of any one of claims 1 , 9 , 10 , 11 or 18 .

24. An isolated recombinant microorganism comprising the polynucleotide of claim 23 .

25. A method for transferring a monosaccharide group to a substrate comprising contacting a NDP-sugar and the substrate with the isolated recombinant microorganism of claim 24 .

26. A method for transferring a glycosyl group to a substrate comprising growing the isolated recombinant microorganism of claim 24 in the presence of the substrate.

Assignments (4)
SECURITY INTEREST Recorded Sep 8, 2025
From: MANUS BIO INC.; STO.PERU I LLC; STO.PERU II LLC; MANUS INTERMEDIATE INC.; MANUS INSCRIPTA, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 072836/0255 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2025
From: EICF AGENT LLC
To: MANUS BIO INC.
Reel/Frame 071247/0658 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2021
From: KUMARAN, AJIKUMAR PARAYIL; DONALD, JASON ERIC; LOVE, AARON; TOOMEY, CHRISTOPHER; SANTOS, CHRISTINE NICOLE S.
To: MANUS BIO INC.
Reel/Frame 057621/0422 →
SECURITY AGREEMENT Recorded Aug 23, 2021
From: MANUS BIO INC
To: EICF AGENT LLC
Reel/Frame 057255/0345 →
Continuity (2)
Provisional Application 62866148 · Jun 25, 2019
Related Publication 20210009968A1 · Jan 14, 2021
Cited By (1)
US 12,234,464